Single Pass, based in Lake Forest, California, is dedicated to advancing medical technology with its innovative disposable bipolar electrocautery device. The company's core mission is to enhance the safety and efficiency of biopsy procedures by preventing bleeding through deep tissue cauterization. Their patented device, designed for single-use, aims to make biopsy processes swift, easy, and safe, addressing a significant need in the medical field for reliable and effective bleeding control during solid organ biopsies.
Notable figures associated with Single Pass include its founding team of medical and engineering experts who have driven the development of this groundbreaking technology. The company has garnered attention and support from key investors in the medical device sector. Single Pass's achievements include securing patents for their unique device and gaining recognition for improving patient outcomes in biopsy procedures. Their impact is marked by enhanced procedural safety and efficiency, contributing to better healthcare practices and patient care.
